MAVERICK CAPITAL LTD - 31 Dec 2025 SCHEDULE 13G/A Report for Rocket Pharmaceuticals, Inc. Common stock, $0.01 par value per share (RCKT)

Filing Manager
MAVERICK CAPITAL LTD
Reporting Manager
Maverick Capital, Ltd.
Security
Rocket Pharmaceuticals, Inc. Common stock, $0.01 par value per share
Symbol
RCKT
Shares outstanding
109,265,652 shares
Disclosed Ownership
2,513,110 shares
Ownership
2.3%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:10:03 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Maverick Capital, Ltd. 2.3% 2,513,110 0 2,513,110 /s/ Trevor Wiessmann* By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Maverick Capital Management, LLC 2.3% 2,513,110 0 2,513,110 /s/ Trevor Wiessmann* Lee S. Ainslie III, Manager
Lee S. Ainslie III 2.3% 2,513,110 0 2,513,110 /s/ Trevor Wiessmann* Lee S. Ainslie III